aluates Reports

$ 0.0

Automative

Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-38I10580

Global Peripheral Parenteral Nutrition PPN and Total Parenteral Nutrition TPN Market Research Report 2022

BUY CHAPTERS

Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Research Report 2025

Code: QYRE-Auto-38I10580

Report

March 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Eurofarma

Corporacion De Laboratorios Farmaceuticos

Baxter International Inc

Kelun Pharma

B. Braun

Fresenius

Teva Pharmaceutical Industries

Pfizer (Hospira)

Ostuka Pharmaceutical

Laboratorios Biogalenic

Laboratorios Finlay

Grifols International

Fresenius Kabi

Sichuan Kelun Pharmaceutical

Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market

The global market for Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) include Eurofarma, Corporacion De Laboratorios Farmaceuticos, Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, Laboratorios Biogalenic, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN).

The Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Report

Report Metric	Details
Report Name	Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market
Segment by Type	Peripheral Parenteral Nutrition (PPN) Total Parenteral Nutrition (TPN)
Segment by Application	Hospital Home
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Eurofarma, Corporacion De Laboratorios Farmaceuticos, Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, Laboratorios Biogalenic, Laboratorios Finlay, Grifols International, Fresenius Kabi, Sichuan Kelun Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market report?

Ans: The main players in the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market are Eurofarma, Corporacion De Laboratorios Farmaceuticos, Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, Laboratorios Biogalenic, Laboratorios Finlay, Grifols International, Fresenius Kabi, Sichuan Kelun Pharmaceutical

What are the Application segmentation covered in the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market report?

Ans: The Applications covered in the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market report are Hospital, Home

What are the Type segmentation covered in the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market report?

Ans: The Types covered in the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market report are Peripheral Parenteral Nutrition (PPN), Total Parenteral Nutrition (TPN)

Recommended Reports

Peripheral Catheters Devices

Parenteral Drugs Packaging

Nutrition Therapy Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Peripheral Parenteral Nutrition (PPN)

1.2.3 Total Parenteral Nutrition (TPN)

1.3 Market by Application

1.3.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Home

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Perspective (2020-2031)

2.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Growth Trends by Region

2.2.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Historic Market Size by Region (2020-2025)

2.2.3 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Region (2026-2031)

2.3 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Dynamics

2.3.1 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Industry Trends

2.3.2 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Drivers

2.3.3 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Challenges

2.3.4 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Players by Revenue

3.1.1 Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Players by Revenue (2020-2025)

3.1.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Players (2020-2025)

3.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue

3.4 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Concentration Ratio

3.4.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue in 2024

3.5 Global Key Players of Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Head office and Area Served

3.6 Global Key Players of Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN), Product and Application

3.7 Global Key Players of Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Breakdown Data by Type

4.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Historic Market Size by Type (2020-2025)

4.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Type (2026-2031)

5 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Breakdown Data by Application

5.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Historic Market Size by Application (2020-2025)

5.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2020-2031)

6.2 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2020-2025)

6.4 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2020-2031)

7.2 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2020-2025)

7.4 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2020-2031)

8.2 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (2020-2025)

8.4 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2020-2031)

9.2 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2020-2025)

9.4 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2020-2031)

10.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2020-2025)

10.4 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Eurofarma

11.1.1 Eurofarma Company Details

11.1.2 Eurofarma Business Overview

11.1.3 Eurofarma Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction

11.1.4 Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

11.1.5 Eurofarma Recent Development

11.2 Corporacion De Laboratorios Farmaceuticos

11.2.1 Corporacion De Laboratorios Farmaceuticos Company Details

11.2.2 Corporacion De Laboratorios Farmaceuticos Business Overview

11.2.3 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction

11.2.4 Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

11.2.5 Corporacion De Laboratorios Farmaceuticos Recent Development

11.3 Baxter International Inc.

11.3.1 Baxter International Inc. Company Details

11.3.2 Baxter International Inc. Business Overview

11.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction

11.3.4 Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

11.3.5 Baxter International Inc. Recent Development

11.4 Kelun Pharma

11.4.1 Kelun Pharma Company Details

11.4.2 Kelun Pharma Business Overview

11.4.3 Kelun Pharma Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction

11.4.4 Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

11.4.5 Kelun Pharma Recent Development

11.5 B. Braun

11.5.1 B. Braun Company Details

11.5.2 B. Braun Business Overview

11.5.3 B. Braun Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction

11.5.4 B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

11.5.5 B. Braun Recent Development

11.6 Fresenius

11.6.1 Fresenius Company Details

11.6.2 Fresenius Business Overview

11.6.3 Fresenius Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction

11.6.4 Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

11.6.5 Fresenius Recent Development

11.7 Teva Pharmaceutical Industries

11.7.1 Teva Pharmaceutical Industries Company Details

11.7.2 Teva Pharmaceutical Industries Business Overview

11.7.3 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction

11.7.4 Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

11.7.5 Teva Pharmaceutical Industries Recent Development

11.8 Pfizer (Hospira)

11.8.1 Pfizer (Hospira) Company Details

11.8.2 Pfizer (Hospira) Business Overview

11.8.3 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction

11.8.4 Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

11.8.5 Pfizer (Hospira) Recent Development

11.9 Ostuka Pharmaceutical

11.9.1 Ostuka Pharmaceutical Company Details

11.9.2 Ostuka Pharmaceutical Business Overview

11.9.3 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction

11.9.4 Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

11.9.5 Ostuka Pharmaceutical Recent Development

11.10 Laboratorios Biogalenic

11.10.1 Laboratorios Biogalenic Company Details

11.10.2 Laboratorios Biogalenic Business Overview

11.10.3 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction

11.10.4 Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

11.10.5 Laboratorios Biogalenic Recent Development

11.11 Laboratorios Finlay

11.11.1 Laboratorios Finlay Company Details

11.11.2 Laboratorios Finlay Business Overview

11.11.3 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction

11.11.4 Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

11.11.5 Laboratorios Finlay Recent Development

11.12 Grifols International

11.12.1 Grifols International Company Details

11.12.2 Grifols International Business Overview

11.12.3 Grifols International Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction

11.12.4 Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

11.12.5 Grifols International Recent Development

11.13 Fresenius Kabi

11.13.1 Fresenius Kabi Company Details

11.13.2 Fresenius Kabi Business Overview

11.13.3 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction

11.13.4 Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

11.13.5 Fresenius Kabi Recent Development

11.14 Sichuan Kelun Pharmaceutical

11.14.1 Sichuan Kelun Pharmaceutical Company Details

11.14.2 Sichuan Kelun Pharmaceutical Business Overview

11.14.3 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction

11.14.4 Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

11.14.5 Sichuan Kelun Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Eurofarma

Corporacion De Laboratorios Farmaceuticos

Baxter International Inc

Kelun Pharma

B. Braun

Fresenius

Teva Pharmaceutical Industries

Pfizer (Hospira)

Ostuka Pharmaceutical

Laboratorios Biogalenic

Laboratorios Finlay

Grifols International

Fresenius Kabi

Sichuan Kelun Pharmaceutical

List of Tables

Table 1. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Peripheral Parenteral Nutrition (PPN)

Table 3. Key Players of Total Parenteral Nutrition (TPN)

Table 4. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Region (2020-2025)

Table 8. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Region (2026-2031)

Table 10. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Trends

Table 11. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Drivers

Table 12. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Challenges

Table 13. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Restraints

Table 14. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Players (2020-2025)

Table 16. Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) as of 2024)

Table 17. Ranking of Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN), Headquarters and Area Served

Table 20. Global Key Players of Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN), Product and Application

Table 21. Global Key Players of Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN), Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Type (2020-2025)

Table 25. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Type (2026-2031)

Table 27. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Application (2020-2025)

Table 29. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Application (2026-2031)

Table 31. North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2026-2031) & (US$ Million)

Table 46. Eurofarma Company Details

Table 47. Eurofarma Business Overview

Table 48. Eurofarma Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product

Table 49. Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025) & (US$ Million)

Table 50. Eurofarma Recent Development

Table 51. Corporacion De Laboratorios Farmaceuticos Company Details

Table 52. Corporacion De Laboratorios Farmaceuticos Business Overview

Table 53. Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product

Table 54. Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025) & (US$ Million)

Table 55. Corporacion De Laboratorios Farmaceuticos Recent Development

Table 56. Baxter International Inc. Company Details

Table 57. Baxter International Inc. Business Overview

Table 58. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product

Table 59. Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025) & (US$ Million)

Table 60. Baxter International Inc. Recent Development

Table 61. Kelun Pharma Company Details

Table 62. Kelun Pharma Business Overview

Table 63. Kelun Pharma Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product

Table 64. Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025) & (US$ Million)

Table 65. Kelun Pharma Recent Development

Table 66. B. Braun Company Details

Table 67. B. Braun Business Overview

Table 68. B. Braun Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product

Table 69. B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025) & (US$ Million)

Table 70. B. Braun Recent Development

Table 71. Fresenius Company Details

Table 72. Fresenius Business Overview

Table 73. Fresenius Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product

Table 74. Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025) & (US$ Million)

Table 75. Fresenius Recent Development

Table 76. Teva Pharmaceutical Industries Company Details

Table 77. Teva Pharmaceutical Industries Business Overview

Table 78. Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product

Table 79. Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025) & (US$ Million)

Table 80. Teva Pharmaceutical Industries Recent Development

Table 81. Pfizer (Hospira) Company Details

Table 82. Pfizer (Hospira) Business Overview

Table 83. Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product

Table 84. Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025) & (US$ Million)

Table 85. Pfizer (Hospira) Recent Development

Table 86. Ostuka Pharmaceutical Company Details

Table 87. Ostuka Pharmaceutical Business Overview

Table 88. Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product

Table 89. Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025) & (US$ Million)

Table 90. Ostuka Pharmaceutical Recent Development

Table 91. Laboratorios Biogalenic Company Details

Table 92. Laboratorios Biogalenic Business Overview

Table 93. Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product

Table 94. Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025) & (US$ Million)

Table 95. Laboratorios Biogalenic Recent Development

Table 96. Laboratorios Finlay Company Details

Table 97. Laboratorios Finlay Business Overview

Table 98. Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product

Table 99. Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025) & (US$ Million)

Table 100. Laboratorios Finlay Recent Development

Table 101. Grifols International Company Details

Table 102. Grifols International Business Overview

Table 103. Grifols International Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product

Table 104. Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025) & (US$ Million)

Table 105. Grifols International Recent Development

Table 106. Fresenius Kabi Company Details

Table 107. Fresenius Kabi Business Overview

Table 108. Fresenius Kabi Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product

Table 109. Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025) & (US$ Million)

Table 110. Fresenius Kabi Recent Development

Table 111. Sichuan Kelun Pharmaceutical Company Details

Table 112. Sichuan Kelun Pharmaceutical Business Overview

Table 113. Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product

Table 114. Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025) & (US$ Million)

Table 115. Sichuan Kelun Pharmaceutical Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Picture

Figure 2. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Type: 2024 VS 2031

Figure 4. Peripheral Parenteral Nutrition (PPN) Features

Figure 5. Total Parenteral Nutrition (TPN) Features

Figure 6. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Home Case Studies

Figure 10. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Report Years Considered

Figure 11. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Region: 2024 VS 2031

Figure 14. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Players in 2024

Figure 15. Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue in 2024

Figure 17. North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Country (2020-2031)

Figure 19. United States Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Country (2020-2031)

Figure 23. Germany Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Region (2020-2031)

Figure 31. China Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Country (2020-2031)

Figure 39. Mexico Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Country (2020-2031)

Figure 43. Turkey Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Eurofarma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

Figure 47. Corporacion De Laboratorios Farmaceuticos Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

Figure 48. Baxter International Inc. Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

Figure 49. Kelun Pharma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

Figure 50. B. Braun Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

Figure 51. Fresenius Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

Figure 52. Teva Pharmaceutical Industries Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

Figure 53. Pfizer (Hospira) Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

Figure 54. Ostuka Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

Figure 55. Laboratorios Biogalenic Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

Figure 56. Laboratorios Finlay Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

Figure 57. Grifols International Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

Figure 58. Fresenius Kabi Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

Figure 59. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350